These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6834635)

  • 21. Novel human in vitro system for evaluating antimycobacterial vaccines.
    Kampmann B; Tena GN; Mzazi S; Eley B; Young DB; Levin M
    Infect Immun; 2004 Nov; 72(11):6401-7. PubMed ID: 15501770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials.
    Springett VH; Sutherland I
    Tuber Lung Dis; 1994 Jun; 75(3):227-33. PubMed ID: 7919317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79.
    Bagshawe A; Scott GC; Russell DA; Wigley SC; Merianos A; Berry G
    Bull World Health Organ; 1989; 67(4):389-99. PubMed ID: 2680140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prophylaxis of tuberculosis and vaccination with BCG. A recent study].
    Tidjani O; Grunitzky B; Sadjo H; Guérin N
    Ann Pediatr (Paris); 1992 Feb; 39(2):99-105. PubMed ID: 1580535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF; Chinn DN; Rodgers CR; Mackintosh CG
    Tuberculosis (Edinb); 2001; 81(1-2):133-9. PubMed ID: 11463234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review.
    Lugosi L
    Tuber Lung Dis; 1992 Oct; 73(5):252-61. PubMed ID: 1493232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.
    Smith D; Wiegeshaus E; Balasubramanian V
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S77-80. PubMed ID: 11010828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCG: bad news from India.
    Lancet; 1980 Jan; 1(8159):73-4. PubMed ID: 6101419
    [No Abstract]   [Full Text] [Related]  

  • 30. New vaccines for the prevention of tuberculosis.
    von Reyn CF; Vuola JM
    Clin Infect Dis; 2002 Aug; 35(4):465-74. PubMed ID: 12145732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCG vaccination and WHO's global strategy for tuberculosis control 1948-1983.
    Brimnes N
    Soc Sci Med; 2008 Sep; 67(5):863-73. PubMed ID: 18573583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population.
    Comstock GW; Webster RG
    Am Rev Respir Dis; 1969 Dec; 100(6):839-45. PubMed ID: 5353858
    [No Abstract]   [Full Text] [Related]  

  • 34. [BCG vaccination in France].
    Grosset J; Jarlier V; Lecoeur H
    Rev Mal Respir; 1987; 4(2):69-74. PubMed ID: 3589111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial.
    Rodrigues LC; Pereira SM; Cunha SS; Genser B; Ichihara MY; de Brito SC; Hijjar MA; Dourado I; Cruz AA; Sant'Anna C; Bierrenbach AL; Barreto ML
    Lancet; 2005 Oct; 366(9493):1290-5. PubMed ID: 16214599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cattle as a model for development of vaccines against human tuberculosis.
    Buddle BM; Skinner MA; Wedlock DN; de Lisle GW; Vordermeier HM; Glyn Hewinson R
    Tuberculosis (Edinb); 2005; 85(1-2):19-24. PubMed ID: 15687023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis: looking beyond BCG vaccines.
    Mustafa Abu S; Al-Attiyah R
    J Postgrad Med; 2003; 49(2):134-40. PubMed ID: 12867689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An American view of BCG vaccination, illustrated by results of a controlled trial in Puerto Rico.
    Comstock GW; Edwards PQ
    Scand J Respir Dis; 1972; 53(4):207-17. PubMed ID: 4565596
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BCG replacement vaccine VPM1002: from drawing board to clinical trial.
    Kaufmann SH; Cotton MF; Eisele B; Gengenbacher M; Grode L; Hesseling AC; Walzl G
    Expert Rev Vaccines; 2014 May; 13(5):619-30. PubMed ID: 24702486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.